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specifically applied to the unique chal-
lenges ofstudying plants. The book claims
to assume no specialized knowledge of
plant biology and indeed goes in some
detail into necessary background informa-
tion and terms. And herein lies the prob-
lem with this book. By being limited to so
few pages, the book at times seems to pick
and choose what to focus on, covering in
excellent detail and clarity some areas,
while giving short shrift to others.
The introduction of the book effec-
tively lays out the plan for the book and
most importantly to me, explains why
there is value in writing a book specifical-
ly devoted to plant genomics. The author
explains that some of the unique charac-
teristics of plants, such as the large vari-
ability in genome size and the frequent
occurrence of polyploidization, provide
particular challenges to the application of
genomic tools and research. Needless to
say, with the growing body ofresearch on
plant biology facillitated by genomics, a
book to summarize andimpose some order
on this field is useful. The author also
points out the importance of research on
crop plants and addresses some ofthe con-
troversies surrounding genetic manipula-
tion ofplants.
Chapter 1 gives a nice overview ofthe
structure ofplant genomes andprovides an
excellent introduction to both what makes
plants unique and different from other fre-
quently studied non-plant organisms. The
following chapters take the reader on an
informative tour of the field of genomics
covering topics such as sequencing strate-
gies, acquiring functional information,
gene discovery, and the use ofmicroarrays.
There are some areas thatread more like an
introduction to genomics in general, with
few references to plants in particular.
The last few chapters focus in more
on plants in particular with a chapter on
interactions with the external environment
and a discussion of traits that are con-
trolled by multiple genes. These chapters
cover information on research quite rele-
vant to plant research and provide lots of
information clearly and concisely. The
section on plant resistance is particularly
noteworthy. The last chapters cover
resources in bioinformatics that are avail-
able to researchers and a short section on
some bioethical concerns that plant
biotechnology has raised.
Overall, the author does an admirable
job of summarizing a large and growing
field. I also appreciate his attempts to
explore the ways in which genomics are
applied to plant research and some of the
recent advances in this area. However, my
greatest complaint is that the author seems
to have been forced to pick and choose
areas to focus on, rather than giving a
more general summary. Perhaps less detail
and a broader paintbrush would have been
more successful. Also, dare I say, the book
could have also benefitted from a few
more pages.
Irvin Pan
Yale University
The Science and Ethics of
Engineering the Human Germ Line:
Mendel's Maze. By Jon W. Gordon.
Hoboken, New Jersey: Wiley-Liss,
2003, 286 pp. $49.95.
One can't usually judge a book by its
cover, but this might be an exception. On
the cover of The Science and Ethics of
Engineering the Human Germ Line, the
bright yellow word "Science" dwarfs the
rest of the plain white words. The content
of the book reflects this emphasis. Dr.
Gordon is a professor of Geriatrics and
Adult Development and of Obstetrics,
Gynecology and Reproductive Medicine
at Mount Sinai. He was also the first per-
son to create a transgenic mouse. He wrote
this book in order to integrate the relevant
science, provide a sufficient scientific
understanding for the public, develop a
framework for thinking about ethics and
biotechnology and, finally, shed some200 Book reviews
light on some of biases against women in
thinking about these areas.
On the whole, the book is a success.
The first three-fifths of the book attempts
to inform the reader ofpertinent science in
the fields of molecular biology, genetics,
developmental biology, and reproductive
biology. This is directed not only at the lay
public, but also at other scientists who, in
Gordon's opinion, can be rather misin-
formed about scientific fields outside their
own specialties. He cites one example ofa
colleague arguing that because a man died
of a brain tumor and his twin didn't, they
could not be identical. Gordon's book pro-
vides enough information to prevent not
only such blatant mistakes, but more sub-
tle ones as well. Even for the scientifically
trained, this book is instructive. Gordon's
distillations are simple, effective, and have
surprising depth. Unfortunately, a late
publishing decision to not run the figures
in black and white without correcting the
text creates some confusing, but this is
only a minor complaint. His impulse to
involve every citizen is in the best tradi-
tion ofAmerican politics, and his skill in
making this possible is remarkable.
Gordon's ethical analysis, however, is
somewhat uneven. As for some of the
strenghts, he emerges as a strong defender
of women's welfare, and highlights the
emotional trauma and compromised posi-
tion of women in both sides ofthe debates
on cloning, genetic engineering, and all of
reproductive technology ethics. This is a
very welcome addition to these weighty
considerations. Restricting a woman's
control over her own body certainly can
cause suffering, but so can rushing for-
ward with technologies that depend on
surrogate mothers, egg donors, and all of
the other roles that women will be expect-
ed to play - roles that typically involve
invasive medical techniques and other
emotionally trying experiences.
Additionally, Gordon uses his strong
scientific insights to slice through some of
the Gordian knots of reproductive ethics.
He argues that many concerns are based
on scientific impossibilities, or, at the very
least, scientific longshots. Genetic engi-
neering will only allow the control oftraits
to the degree that identical twins are simi-
lar. Any chaotic developmental process,
like personality traits, will always be
beyond the reach of genetic replacement.
Moreover, by placing emerging technolo-
gies, including embryonic stem cells, in
the context of extant therapies, and rating
across safety, cost, efficacy and morbidity,
he shows that it will almost always make
the most sense to use natural conception,
followed by standard genetic screening
and possible abortion, than to involve
complicated, invasive, expensive and
often dangerous technologies.
In his final chapters, however, his
pragmatism does a disservice. His disdain
for ethics surfaces in his use of quotation
marks for: "ethics," "morals," "deep" phi-
losophy. This kind of thinking, he writes,
is "fun" and requires "alicense to be silly."
The intensely clear thinking stops here.
Instead the readerreceives superficial - it
is my turn to employ ironic quotes
"legal" analysis, as well as rare moments
of confused logic: "We can distinguish
'elective' from 'therapeutic' gene transfer
...[because] none of the great geniuses in
history, from Leonardo daVinci to Goethe
to Einstein, was produced by genetic engi-
neering." His legal argument essentially
maintains that unless objective fact or
social consensus exists, no prohibitive law
is warranted. Laws based on moral values
are to be avoided. These standards would
have prevented laws against incest as well
as most of our civil rights legislation. It
would have been impossible to assert the
inalienable rights of minorities or women
as a fact, especially at a time where denial
of access to resources made their achieve-
ments and status appear inferior to white
males. And certainly no social consensusBook reviews 201
existed at these pivotal and revolutionary
parts of our history.
In his defense, Gordon believes all
ethical discourse should wait until the
technology arrives, as the debate will turn
on real details, not speculations. Other
inconsistencies and difficulties plague
these last chapters, but to dwell on them is
to do an injustice to an otherwise wonder-
ful and much needed contribution to the
contemporary fears about biomedical sci-
ence. Gordon's basic message, and the
source of his antipathy to legal interven-
tion, is that biotechnology, like every
extension of human power over other
humans, can obviously serve to promul-
gate the inequities of race, class, and sex,
but it also can challenge society to live up
to its ideals, and provide the impetus for
progressive change. We cannot only invent
new technologies, we must also reinvent
society to be worthy ofthem. This power-
ful ethical message, combined with
Gordon's scientific acumen, make for a
simultaneously accessible and thoughtful
book. This book, and others like it, will
serve a vital role in enabling a democratic
resolution ofthese contentious issues.
Paul Kalanithi
Yale School ofMedicine
Signal Trandsuction and Human
Disease. Toren Finkel and J. Silvio
Gutkind, Editors. Hoboken, New
Jersey: John Wiley & Sons; 2003, 488
pp. $99.95
In Signal Transduction and Human
Disease, Drs. Finkel and Gutkind have
attempted to produce the first text to their
knowledge that "straddle[s] the productive
interface between modern biology and
modern medicine." It is an entirely worthy
goal, and their note that this is but a first
edition suggests that they are willing to
grapple with the Sisyphean task ofcaptur-
ing the dynamic field of signal transduc-
tion in successive static snapshots. Their
clear commitment to the inclusion of
recent data is evident by endnotes in sev-
eral of the chapters apparently added sub-
sequent to the receipt ofgalley proofs.
In a nod to standard medical textbook
practice, they have chosen to partition
their text into chapters based on specific
diseases and disease processes, fully cog-
nizant that this scheme slights and frag-
ments treatment of complex signal trans-
duction pathways such as MAPK,
JAK/STAT, NF-kB, and NO. The targeted
areas include cardiology, oncology,
endocrinology, infectious disease,
rheumatology, neurology, and psychology.
They elected to subdivide some of these
areas further, such as in endocrinology,
with a single chapter devoted to the mole-
cular basis of diabetes, while the next
focused on the endocrinological sequelae
of dysregulated G-protein coupled recep-
tor (GPCR) function.
Each chapter is structured much along
the lines of a review article in a basic sci-
ence journal, but augmented with clinical
correlations. Individual authors have cho-
sen to integrate their clinical correlates in
a variety offashions, with varying degrees
of success. Unfortunately, a common
approach was the rather pedestrian tactic
of reserving clinical observations for the
end ofthe chapter, and give the impression
of adding clinical notes only for effect.
Such an uninspired approach tends to sub-
vert the unique opportunity that this text
provides, leading to a mere juxtaposition
ofdisciplines rather than a true integration
ofthem.
This text otherwise suffers on several
fronts, not least of which is poor proof-
reading coupled with the indiscriminate
and overzealous use of automated spell-
checking, most evident in the introductory
pages. One of the more egregious exam-
ples would have us believe that Nobel lau-
reates are really "Noble" laureates. The
quality ofthe figures also varies immense-
ly between authors and chapters, with